15 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Diehn, Radiation Oncologist in Stanford, CA?
Dr. Maximilian Diehn is a Radiation Oncologist, who primarily practices in Stanford, CA with 2 additional practice locations. He has been practicing for over 15 years and is board certified. Dr. Diehn completed his residency at Stanford Hospital and Clinics - Radiation Oncology. Dr. Diehn is fluent in English and German, and is currently seeing new patients. Dr. Diehn’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Diehn’s office at (650) 723-6171.
What are Areas of Expertise for Dr. Diehn?
Dr. Maximilian Diehn is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Diehn empowers patients to confidently navigate their health journey, specializing in Clinical Trials, Lung Cancer, Thymoma and Thymic Cancer, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Diehn is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Diehn go to medical school and complete their residency?
Residency: Stanford Hospital and Clinics - Radiation Oncology | Stanford Hospital & Clinics
Is Dr. Diehn board certified as a Radiation Oncologist?
Yes, Dr. Maximilian Diehn is board certified by the American Board of Radiology , American Board of Radiology since 2010
What languages does Dr. Diehn speak?
Dr. Diehn and their clinical team can communicate with patients in the following languages:
English
German
What conditions does a Radiation Oncologist like Dr. Diehn typically treat?
As a Radiation Oncologist, Dr. Diehn diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Diehn. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Lung Cancer
- Right lung cancer
- Bronchial cancer
- Malignant neoplasm of lung
- Left Lung Cancer
- Bronchial Cancer
- Malignant Lung Tumor
- Upper Lobe Lung Cancer
- Right upper lobe lung cancer
ICD-10 Codes:
- C3491: Malignant neoplasm of unspecified part of right bronchus or lung
- C3492: Malignant neoplasm of unspecified part of left bronchus or lung
- C3412: Malignant neoplasm of upper lobe, left bronchus or lung
- C3411: Malignant neoplasm of upper lobe, right bronchus or lung
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
What procedures does a Radiation Oncologist like Dr. Diehn typically perform?
As a Radiation Oncologist, procedures performed by Dr. Maximilian Diehn may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
Please contact Dr. Diehn's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Diehn accept my insurance?
Dr. Diehn accepts most major insurance plans. Important: Please call our office at (650) 723-6171 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Diehn accept in Stanford, CA?
Dr. Diehn in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Federal government of the United States
Kaiser Permanente
Medicaid
Medicare
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Diehn's office located?
Recognitions
Awards
National Institute of Health
NIH Director's New Innovator Award
V Foundation Scholar Grant, V Foundation
Walter H. Coulter Translational Research Grant, Walter H. Coulter Fou
Department of Defense
Lung Cancer Research Program Promising Clinician Research Award
Doris Duke Charitable Foundation
Doris Duke Clinical Scientist Development Award
Edward Mallinckrodt, Jr. Foundation Grant, Edward Mallinckrodt, Jr. F
Sidney Kimmel Foundation
Sidney Kimmel Scholar Award
Stanford University
Henry S. Kaplan Memorial Prize for Teaching
Donald E. and Delia B. Baxter Foundation
Donald E. and Delia B. Baxter Foundation Faculty Scholar Award
Stanford University
Malcolm A. Bagshaw Award
RSNA Research Resident/Fellow Grant, Radiological Society of North Am
ASTRO Residents in Radiation Oncology Research Seed Grant, American S
Radiological Society of North America (RSNA)
Roentgen Resident/Fellow Research Award
Holman Research Pathway, American Board of Radiology (ABR)
American Society for Therapeutic Radiology and Oncology (ASTRO)
Annual Meeting Basic Science Travel Grant Award
Jr. Award for Research, Department of Medicine, Stanford University
Franklin G. Ebaugh
Stanford University
Medical Scientist Training Program
Harvard University
Thomas Temple Hoopes Prize for outstanding senior thesis
Publications
An ultrasensitive method for quantitating circulating tumor D with broad patient coverage
, 2014
Neuregulin Autocrine Sigling Promotes Self-Renewal of Breast Tumor
, 2014
Association of reactive oxygen species levels and radioresistance in cancer stem cells
, 2009
A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non
, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
, 2014
Illumiting Radiogenomic Characteristics of Gliobl
, 2014
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor
, 2013
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.
, 2013
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
, 2013
The Optimal Use of Radiotherapy in Small Cell Lung Cancer
, 2013
Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
, 2012
Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors
, 2012
Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
, 2012
HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL
, 2011
Reducing 4D CT artifacts using optimized sorting based on atomic similarity
, 2011
Tumor Volume as a Potential Imaging-Based Risk
, 2011
STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
, 2010
Identification, molecular characterization
, 2009
Downregulation of miR-200c Links Breast Cancer Stem Cells with Normal Stem Cells
, 2009
Therapeutic Implications of the Cancer Stem Cell Hypothesis
, 2009
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
, 2008
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment
, 2008
Cancer stem cells and radiotherapy: New insights into tumor radioresistance
, 2006
Genome-scale identification of membrane-associated human mRs
, 2006
Gene expression profiling reveals molecularly
, 2005
Differential gene expression in atomical compartments of the human eye
, 2005
Presyptic homeostasis at CNS nerve termils compensates for lack of a key Ca2+ entry pathway
, 2004
T cell receptor-independent basal sigling via Erk and Abl kises suppresses RAG gene expression
, 2003
T cell receptor-independent basal sigling via Erk and Abl kises suppresses RAG gene expression.
, 2003
Individuality and variation in gene expression patterns in human blood
, 2003
SOURCE: a unified genomic resource of functiol annotations, ontologies, and gene expression data
, 2003
Genomic expression programs and the integration of the CD28 costimulatory sigl in T cell activation
, 2002
Transformation of follicular lymphoma to diffuse large-cell lymphoma
, 2002
Transcriptiol response of human mast cells stimulated via the Fc
, 2002
Stereotyped and specific gene expression programs in human inte immune responses to bacteria
, 2002
Transcriptiol programs activated by exposure of human prostate cancer cells to androgen
, 2002
Comparing functiol genomic datasets
, 2001
Examining the living genome in health and disease with D microarrays
, 2000
Large-scale identification of secreted and membrane-associated gene products using D microarrays
, 2000
Biochemical interactions integrating Itk with the T cell receptor-initiated sigling cascade
, 2000
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
, 2014
Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor
, 2014
Association of reactive oxygen species levels and radioresistance in cancer stem cells
, 2009
A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non
, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
, 2014
Illuminating Radiogenomic Characteristics of Gliobl
, 2014
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor
, 2013
4D CT lung ventilation images are affected by the 4D CT sorting method
, 2013
Clinical impact of dose overestimation by effective path length calculation
, 2013
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.
, 2013
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
, 2013
The Optimal Use of Radiotherapy in Small Cell Lung Cancer
, 2013
Metabolic imaging metrics correlate with survival
, 2012
Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
, 2012
Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors
, 2012
Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
, 2012
What the Diagnostic Radiologist Needs to Know about Radiation Oncology
, 2011
HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL
, 2011
Reducing 4D CT artifacts using optimized sorting based on anatomic similarity
, 2011
Tumor Volume as a Potential Imaging-Based Risk
, 2011
The Myc Connection: ES Cells and Cancer
, 2010
STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
, 2010
Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?
, 2010
Identification, molecular characterization
, 2009
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
, 2009
Therapeutic Implications of the Cancer Stem Cell Hypothesis
, 2009
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
, 2008
Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors
, 2008
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment
, 2008
Cancer stem cells and radiotherapy: New insights into tumor radioresistance
, 2006
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
, 2006
Genome-scale identification of membrane-associated human mRNAs
, 2006
Gene expression profiling reveals molecularly
, 2005
Differential gene expression in anatomical compartments of the human eye
, 2005
A method for detecting and correcting feature misidentification on expression microarrays
, 2004
Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway
, 2004
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression
, 2003
Gene expression patterns in ovarian carcinomas
, 2003
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression.
, 2003
Individuality and variation in gene expression patterns in human blood
, 2003
SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data
, 2003
Genomic expression programs
, 2002
Transformation of follicular lymphoma to diffuse large-cell lymphoma
, 2002
Transcriptional response of human mast cells stimulated via the Fc
, 2002
In vivo regulation of human skeletal muscle gene expression by thyroid hormone
, 2002
Stereotyped and specific gene expression programs in human innate immune responses to bacteria
, 2002
Transcriptional programs activated by exposure of human prostate cancer cells to androgen
, 2002
Comparing functional genomic datasets
, 2001
Examining the living genome in health and disease with DNA microarrays
, 2000
Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
, 2000
Degradation of proteins from the ER of S
, 2000
Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade
, 2000
What is Dr. Diehn's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Diehn's National Provider Identifier (NPI) number is 1174719850.
What common questions do patients ask about Dr. Diehn?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Diehn
What is Dr. Maximilian Diehn's specialty?
Dr. Diehn is a Radiation Oncologist near Stanford, CA.
What does a Radiation Oncologist do?
A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors.
Is this Dr. Maximilian Diehn affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Diehn is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Radiation Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Radiation Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Maximilian Diehn accepting new patients in Stanford, CA?
Yes, Dr. Maximilian Diehn is accepting new patients at this time.
Does Dr. Maximilian Diehn offer online booking?
Please contact Dr. Diehn's office at (650) 723-6171 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Maximilian Diehn?
Please contact Dr. Diehn's office at (650) 723-6171 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Maximilian Diehn have?
Dr. Maximilian Diehn is certified by the American Board of Radiology.
Other Radiation Oncologist Near Stanford, CA
Radiation Oncologist
Accepting patients
Radiation Oncologist
Accepting patients
Radiation Oncologist
Accepting patients